市場調査レポート

商品コード

1522898

心肺運動負荷試験（CPET）の市場規模、シェア、成長分析：製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024-2031年

Cardiopulmonary Exercise Testing Market Size, Share, Growth Analysis, By Product, By Application, By End-user, By Region - Industry Forecast 2024-2031

出版日: 2024年07月19日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

心肺運動負荷試験（CPET）の市場規模は、2022年に35億3,000万米ドルと評価され、予測期間（2024-2031年）のCAGRは4.7%で、2023年の37億米ドルから2031年には73億米ドルに成長すると予測されています。

心血管疾患は、世界のヘルスケア部門にとって重大かつエスカレートする課題であり、早急な対応と効果的な診断アプローチが求められています。その顕著な例が、欧州心臓ネットワークが2021年に発表したデータであり、欧州連合（EU）全域における心血管疾患の深刻な影響を浮き彫りにしています。それによると、この地域では6,000万人以上が心血管疾患を抱えており、毎年1,300万人近くが新たに心血管疾患と診断されています。この高い有病率は、心臓病の早期発見と介入を可能にするために、負荷試験法の広範な採用を含む予防的措置の重要な必要性を強調しています。心血管疾患の負担の増大は、世界中の医療システムに大きな圧力をかけており、この深刻化する公衆衛生の課題に対処するための包括的な戦略と高度な診断ツールの必要性を強調しています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

COSMED SRL（Italy）
Vyaire Medical Inc.（USA）
MGC Diagnostics Corporation（USA）
Hill-Rom Holdings Inc.（USA）
GE Healthcare（USA）
Koninklijke Philips NV（Netherlands）
Nihon Kohden Corporation（Japan）
Schiller AG（Switzerland）
Masimo Corporation（USA）
Cardinal Health（USA）
CareFusion Corporation（USA）
SunTech Medical, Inc.（USA）
Geratherm Medical AG（Germany）
Spacelabs Healthcare（USA）
Welch Allyn（USA）
Microlife Medical Home Solutions Inc.（Switzerland）
Medisoft SA（Belgium）
CAIRE Inc.（USA）
Becton, Dickinson and Company（USA）

Product Code: SQMIG35A2819

Cardiopulmonary Exercise Testing Market size was valued at USD 3.53 billion in 2022 and is poised to grow from USD 3.70 billion in 2023 to USD 7.3 billion by 2031, growing at a CAGR of 4.7% in the forecast period (2024-2031).

Cardiovascular diseases pose a significant and escalating challenge for the global healthcare sector, demanding urgent attention and effective diagnostic approaches. A striking example is data published by the European Heart Network in 2021, highlighting the profound impact of cardiovascular diseases across the European Union. According to the report, more than 60 million individuals in the region live with cardiovascular disease, with nearly 13 million new cases diagnosed annually. This high prevalence underscores the critical necessity for proactive measures, including widespread adoption of stress testing procedures, to enable early detection and intervention in heart diseases. The growing burden of cardiovascular conditions places substantial pressure on healthcare systems worldwide, underscoring the need for comprehensive strategies and advanced diagnostic tools to address this escalating public health challenge.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiopulmonary Exercise Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiopulmonary Exercise Testing Market Segmental Analysis

The cardiopulmonary exercise testing market is segmented into product, application, end user, and region. Based on product, the cardiopulmonary exercise testing market is segmented into single-photon emission computed tomography, cardiopulmonary exercise testing systems, echocardiogram, pulse oximeters, stress blood pressure monitors and others. Based on application, the market is segmented into oxygen uptake, carbon dioxide, minute ventilation, and anaerobic threshold. Based on end-user, the cardiopulmonary exercise testing market is segmented into diagnostic centers, ambulatory centers, clinics and hospitals and others. Based on region, the cardiopulmonary exercise testing market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.

Drivers of the Cardiopulmonary Exercise Testing Market

The integration of cardiopulmonary exercise testing (CPET) with telemedicine platforms and simple wearable devices represents a transformative advancement in healthcare. This integration empowers individuals through remote monitoring and enables home-based research. Telemedicine platforms allow patients to undergo CPET from the convenience of their homes, overcoming geographical constraints and broadening access to essential health services. The inclusion of wearable devices enhances this approach further, as they enable individuals to capture real-time data and transmit it to healthcare providers. This plays a crucial role in preventive healthcare, early detection, and continuous management of cardiopulmonary conditions.

Restraints in the Cardiopulmonary Exercise Testing Market

The growth of the cardiopulmonary exercise testing market faces challenges due to the considerable costs involved in these diagnostic procedures. The high expenses associated with acquiring, installing, and maintaining cardiopulmonary exercise testing equipment serve as a substantial barrier to market expansion. This financial hurdle could restrict access to these testing methods for healthcare providers and patients alike, thereby potentially slowing down the adoption of cardiopulmonary exercise testing on a broader scale. Economic factors related to these tests may present difficulties for healthcare facilities, especially in areas with limited healthcare budgets.

Market Trends of the Cardiopulmonary Exercise Testing Market

The cardiopulmonary exercise testing market is set to expand, driven by a variety of exercise testing systems offered by major industry players, each offering numerous benefits and continuous advancements. A notable example occurred in May 2022, when MGC Diagnostics, a leading global medical technology company, announced a strategic collaboration with UK-based med-tech firm Bedfont Scientific Ltd. Known for its expertise in breath analysis, Bedfont Scientific has developed the NObreath fractional exhaled nitric oxide test monitor, suitable for both hospital and remote settings. Such collaborative ventures and partnerships among key industry leaders are expected to significantly contribute to the growth of the cardiopulmonary exercise testing market. These initiatives underscore a commitment to introducing cutting-edge technologies and solutions, driving expansion in this sector over the forecast period.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Pricing Analysis
Start Up Analysis
Regulatory Landscape
Patent Analysis
Pipeline Analysis
Key Success Factors
Market Attractiveness Index
Degree of Competition
Top Investment Pockets
Ecosystem Mapping

Cardiopulmonary Exercise Testing Market by Product

Market Overview
Single-photon Emission Computed Tomography
Cardiopulmonary Exercise Testing Systems
Echocardiogram
Pulse Oximeters
Stress Blood Pressure Monitors
Others

Cardiopulmonary Exercise Testing Market by Application

Market Overview
Oxygen Uptake
Carbon Dioxide
Minute Ventilation
Anaerobic Threshold

Cardiopulmonary Exercise Testing Market by End User

Market Overview
Diagnostic Centers
Ambulatory Centers
Clinics & Hospitals
Others

Cardiopulmonary Exercise Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

COSMED SRL (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vyaire Medical Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MGC Diagnostics Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hill-Rom Holdings Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips NV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schiller AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Masimo Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CareFusion Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SunTech Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Geratherm Medical AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Spacelabs Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Welch Allyn (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microlife Medical Home Solutions Inc. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medisoft SA (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CAIRE Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

心肺運動負荷試験（CPET）の市場規模、シェア、成長分析：製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024-2031年

Cardiopulmonary Exercise Testing Market Size, Share, Growth Analysis, By Product, By Application, By End-user, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

心肺運動負荷試験（CPET）市場：製品別

心肺運動負荷試験（CPET）市場：用途別

心肺運動負荷試験（CPET）市場：エンドユーザー別

心肺運動負荷試験（CPET）市場規模：地域別